Gene silencing effect of SiRNA-magnetic modified with biodegradable copolymer nanoparticles on hTERT gene expression in lung cancer cell line

References

• Agrawal N, Dasaradhi P, Mohmmed A, Malhotra P, Bhatnagar R, Mukherjee S. 2003. RNA interference: biology, mechanism, and applications. Microbiol Mol Biol Rev. 67:657–685.
   PubMed Web of Science ®Google Scholar
• Akbarzadeh A, Mikaeili H, Zarghami N, Rahmati M, Barkhordari A, Davaran S. 2012d. Preparation and in vitro evaluation of doxorubicin loaded Fe3O4 magnetic nanoparticles modified with biocompatible copolymers. Int J Nanomedicine. 7:511–526.
   PubMed Web of Science ®Google Scholar
• Akbarzadeh A, Nejati-Koshki K, Mahmoudi Soghrati M, et al. 2013b. In vitro studies of NIPAAM-MAA-VP copolymer coated magnetic nanoparticles for controlled anticancer drug release. JEAS. 3: 108–115.
   Google Scholar
• Akbarzadeh A, Nejati-Koshki K, Mahmoudi Soghrati M, et al. 2013c. In vitro studies of NIPAAM-MAA-VP copolymer coated magnetic nanoparticles for controlled anticancer drug release. JEAS. 3:108–115.
   Google Scholar
• Akbarzadeh A, Rezaei A, Nejati-Koshki K, et al. 2014. Synthesis and physicochemical characterization of biodegradable star-shaped poly lactide-co-glycolide– β -cyclodextrin copolymer nanoparticles containing albumin. J Adv Nanoparticles. 3:1–9.
   Google Scholar
• Akbarzadeh A, Rezaei-Sadabady R, Davaran S, Joo SW, Zarghami N, Hanifehpour Y, et al. 2013a. Liposome: classification, preparation, and applications. Nanoscale Res Lett. 8:102.
   PubMed Web of Science ®Google Scholar
• Akbarzadeh A, Samiei M, Davaran S. 2012c. Magnetic nanoparticles: preparation, physical properties, and applications in biomedicine. Nanoscale Res Letrs. 7:144.
   PubMed Web of Science ®Google Scholar
• Akbarzadeh A, Samiei M, Joo SW, Anzaby M, Hanifehpour Y, Nasrabadi HT, Davaran S. 2012a. Synthesis, characterization and in vitro studies of doxorubicin-loaded magnetic nanoparticles grafted to smart Copolymers on A549 lung cancer cell line. J Nanobiotechnology. 10:46.
   PubMed Web of Science ®Google Scholar
• Akbarzadeh A, Zarghami N, Mikaeili H, Asgari D, Goganian AM, Khaksar Khiabani H, et al. 2012b. Synthesis, characterization and in vitro evaluation of novel polymer-coated magnetic nanoparticles for controlled delivery of doxorubicin. Nanotechnol Sci Appl. 5:1–13.
   PubMedGoogle Scholar
• Armanios M, Greider CW. 2005. Telomerase and cancer stem cells. Cold Spring Harbor Symp Quant Biol. 70:205–208.
   PubMedGoogle Scholar
• Blackburn EH. 2005. Telomeres and telomerase: their mechanisms of action and the effects of altering their functions. FEBS Lett. 579:859–862.
   PubMed Web of Science ®Google Scholar
• Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, et al. 1998. Extention of life-span by introduction of telomerase into normal human cells. Science. 279:349–352.
   PubMed Web of Science ®Google Scholar
• Cartiera MS, Johnson KM, Rajendran V, Caplan MJ, Saltzman WM. 2009. The uptake and intracellular fate of PLGA nanoparticles in epithelial cells. Biomaterials. 30:2790–2798.
   PubMed Web of Science ®Google Scholar
• Chen H, Li Y, Tollefsbol TO. 2009. Strategies targeting telomerase inhibition. Mol Biotechnol. 41:194–199.
   PubMed Web of Science ®Google Scholar
• El Daly H, Martens U. 2007. Telomerase inhibition and telomere targeting in hematopoietic cancer cell lines with small non- nucleosidic synthetic compounds (BIBR1532). Methods Mol Biol. 405:47–60.
   PubMedGoogle Scholar
• Fletcher T, Cathers B, Ravikumar K, Mamiya B, Kerwin S. 2001. Inhibition of human telomerase by 7-deaza-2′-deoxy-guanosine nucleoside triphosphate analogs: Potent inhibition by 6-thio- 7-deaza-2′-deoxyguanosine 5′-triphosphate. Bioorg Chem. 29:36–55.
   PubMed Web of Science ®Google Scholar
• Hu Y, Jiang X, Ding Y, Zhang L, Yang C, Zhang J, et al. 2003. Preparation and drug release behaviors of nimodipine-loaded poly(caprolactone)-poly(ethylene oxide)-polylactide amphiphilic copolymer nanoparticles. Biomaterials. 24:2395–2404.
   PubMed Web of Science ®Google Scholar
• Kalambur V, Han B, Hammer BE, Shield TW, Bischof JC. 2005. In vitro characterization of movement, heating and visualization of magnetic nanoparticles for biomedical applications. Nanotechnology. 16:1221.
   Web of Science ®Google Scholar
• Kazemi F, Zarghami N, Fekri S, Monfaredan A. 2012.β-Cyclodextrin-curcumin complex inhibit telomerase gene expression in T47-D breast cancer cell line. Afr J Biotechnol. 10:19481–19488.
   Google Scholar
• Kedar E, Algi O, Golod G, Babai I, Barenholz Y. 1997. Delivery of cytokines by liposomes. III. Liposome-encapsulated GM-CSF and TNF-alpha show improved pharmacokinetics and biological activity and reduced toxicity in mice.J Immunother. 20:180–193.
   PubMed Web of Science ®Google Scholar
• Kim WJ, Kim SW. 2009. Efficient siRNA Delivery with non-viral polymeric vehicles. Pharm Res. 26:657–666.
   PubMed Web of Science ®Google Scholar
• Lee SH, Sinko PJ. 2006. siRNA—Getting the message out. Eur J Pharm Sci. 27:401–410.
   PubMed Web of Science ®Google Scholar
• Li H, Katik I, Liu J. 2007. Uses of telomerase peptides in anti-tumor immune therapy. Methods Mol Biol. 405:61–86.
   PubMedGoogle Scholar
• Mo Y, Gan Y, Song S, Johnston J, Xiao X, Wientjes MG, Au JL. 2003. Simultaneous targeting of telomeres and telomerase as a cancer therapeutic approach. Cancer Res. 63:579–585.
   PubMed Web of Science ®Google Scholar
• Mollazadeh M, Nejati-Koshki K, Akbarzadeh A, Zarghami N, Nasiri M, Jahanban-Esfahlan R, Alibakhshi A. 2013. PAMAM dendrimers arugment inhibitory effect of curcumin on cancer cell proliferation: possible inhibition of telomerase. Asian Pac J Cancer Prev.14:6925–6929.
   PubMedGoogle Scholar
• Nakamura M, Masutomi K, Kyo S, Hashimoto M, Maida Y, Kanaya T, et al. 2005. Efficient inhibition of human telomerase reverse transcriptase expression by RNA interference sensitizes cancer cells to ionizing radiation and chemotherapy. Hum Gene Ther. 16:859–868.
   PubMed Web of Science ®Google Scholar
• Natarajan S, Chen Z, Wancewicz EV, Monia BP, Corey DR. 2004. Telomerase reverse transcriptase (hTERT) mRNA and telomerase RNA (hTR) as targets for downregulation of telomerase activity. Oligonucleotides. 14:263–273.
   PubMed Web of Science ®Google Scholar
• Nejati-Koshki K, Akbarzadeh A, Pourhasan-Moghadam M, et al. 2013. Inhibition of leptin and leptin receptor gene expression by silibinin- curcumin combination. Asian Pac J Cancer Prev. 14: 6595–6599.
   Web of Science ®Google Scholar
• Nejati-Koshki K, Zarghami N, Pourhassan-Moghaddam M, et al. 2012. Inhibition of leptin gene expression and secretion by silibinin: possible role of estrogen receptors. Cytotechnology. 64:719–726.
   PubMed Web of Science ®Google Scholar
• Phatak P, Burger AM. 2007. Telomerase and its potential for therapeutic intervention. Br J Pharmacol. 152:1003–1011.
   PubMed Web of Science ®Google Scholar
• Qaddoumi MG, Ueda H, Yang J, Davda J, Labhasetwar V, Lee VH. 2004. The characteristics and mechanisms of uptake of PLGA nanoparticles in rabbit conjunctival epithelial cell layers. Pharm Res. 21:641–648.
   PubMed Web of Science ®Google Scholar
• Scherer L, Rossi J. 2004. RNAi applications in mammalian cells. BioTechniques. 36:557–561.
   PubMed Web of Science ®Google Scholar
• Shay JW, Gazdar AF. 1997. Telomerase in the early detection of cancer. J Clin Pathol. 50:106–109.
   PubMed Web of Science ®Google Scholar
• Valizadeh A, Mikaeili H, Samiei M, Farkhani SM, Zarghami N, Kouhi M, et al. 2012. Quantum dots: synthesis, bioapplications, and toxicity Nanoscale. Res Lett. 7:480.
   Google Scholar
• Weinrich SL, Pruzan R, Ma L, Ouellette M, Tesmer VM, Holt SE, et al. 1997. Reconstitution of human telomerase with the catalytic protein subunit hTRT. Nat Genet. 17:498–502.
   PubMed Web of Science ®Google Scholar
• Widder KJ, Senyel AE, Scarpelli GD. 1978. Magnetic microspheres: a model system of site specific drug delivery in vivo. Proc Soc Exp Biol Med. 58:141.
   Google Scholar
• Yallapu MM, Jaggi M, Chauhan SC. 2010. beta-Cyclodextrin-curcumin self-assembly enhances curcumin delivery in prostate cancer cells. Colloids Surf B Biointerfaces. 79:113–125.
   PubMed Web of Science ®Google Scholar
• Zablotskaya A, Segal I, Lukevics E. 2010. Iron oxide-based magnetic nanostructures bearing cytotoxic organosilicon molecules for drug delivery and therapy. Appl Organometa Chem. 24: 150–157.
   Web of Science ®Google Scholar
• Zhang PH, Zou L, Tu ZG. 2006. RNAi-hTERT inhibition hepatocellular carcinoma cell proliferation via decreasing telomerase activity. J Surg Res. 131:143–149.
   PubMed Web of Science ®Google Scholar